Incidence of severe urinary tract infections not increased by initiating sodium–glucose cotransporter 2 inhibitors

First of all, high glycated hemoglobin might initially be a contributing factor. [...]a diabetes‐related condition that includes the duration of diabetes and the presence of microvascular complications is important. [...]identifying the presence of lower UTI at the baseline as a risk of developing s...

Full description

Saved in:
Bibliographic Details
Published inJournal of diabetes investigation Vol. 11; no. 3; pp. 530 - 531
Main Author Yokoyama, Hiroki
Format Journal Article
LanguageEnglish
Published Japan John Wiley & Sons, Inc 01.05.2020
John Wiley and Sons Inc
Wiley
Subjects
Bacteria
Clinical trials
Clinical Trials as Topic - methods
Commentaries
Diabetes
Diabetes mellitus
Glucose
Health risk assessment
Hemoglobin
Humans
Incidence
Microvasculature
Peptides
Severity of Illness Index
Sodium-Glucose Transporter 2 Inhibitors - adverse effects
Sodium-Glucose Transporter 2 Inhibitors - therapeutic use
Studies
Urinary tract
Urinary tract diseases
Urinary tract infections
Urinary Tract Infections - diagnosis
Urinary Tract Infections - drug therapy
Urinary Tract Infections - epidemiology
Urogenital system
Online AccessGet full text

Cover

More Information
Summary:First of all, high glycated hemoglobin might initially be a contributing factor. [...]a diabetes‐related condition that includes the duration of diabetes and the presence of microvascular complications is important. [...]identifying the presence of lower UTI at the baseline as a risk of developing severe upper UTI would be helpful.
ISSN:2040-1116
2040-1124
DOI:10.1111/jdi.13189